References
- DeVita V T, Oliverio V T, Muggia F M. The drug development and clinical trials programs of the Division of Cancer Treatment, National Cancer Institute. Cancer Clin Ttials 1979; 2: 195–216
- Venditti J M. The National Cancer Institute Antitumor Drug Discovery Program, current and future perspectives: a commentary. Cancer Treat Rep 1983; 76: 767–772
- Zubrod C G. Historic milestones in curative chemotherapy. Semin Oncol 1979; 6: 490–505
- Appel P L, Alley M C, Lieber M M, et al. Metabolic stability of experimental chemotherapeutic agents in hepatocyte: tumor cell co-culture. Cancer Chemother Pharmacol 1986; 17: 47–52
- Damon L E, Cadman E C. Advances in rational combination chemotherapy. Cancer Invest 1986; 4: 421–444
- Duncan R, Kopeckova-Rejmanova P, Strohalm J, et al. Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer 1987; 55: 165–174
- Fujimoto K, Oka T, Morimoto M. Antitumor activity of a novel anti-tumor antibiotic, quinocarmycin citrate. Cancer Res 1987; 47: 1516–1522
- Ishiwata I, Ishiwata C, Soma M, et al. Characterization of newly established human ovarian carcinoma cell line: Special reference of the effects of cis-platin on cellular proliferation and release of CA125. Gynecol Oncol 1987; 26: 340–354
- Menconi E, Lepri E, Bonmassar E, et al. An in vitro assay for evaluating chemosensitivity of leukemia cells: Preclinical studies. Int J Tissue React 1986; 8: 485–492
- Salmon S E, Hamburger A W, Soehnlen B, et al. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321–1327
- Scheithauer W, Clark G M, Moyer M P, et al. New screening system for selection of anticancer drugs for treatment of human colorectal cancer. Cancer Res 1986; 46: 2703–2708
- Zylicz Z, Wagener D J, Van Rennes H, et al. In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesis. J Natl Cancer Inst 1987; 78: 701–705
- Gordon R R, Hahn G M, Bagshaw M A, et al. Cell survival and repair of plateau-phase cultures after chemotherapy-relevance to tumor therapy and to the in vitro screening of new agents. Cancer Chemother Rep 1973; 57: 473–475
- Barranco S C, Novack J K. Survival responses of dividing and non-dividing mammalian cells treated with hydroxyurea, arabinosylcytosine, or adriamycin. Cancer Res 1974; 34: 1616–1618
- Hahn G M, Gordon L F, Kurkjian S D. Response of cycling and noncycling cells to l,3-bis(chloroethyl)-l-nitrosourea and to bleomycin. Cancer Res 1974; 34: 2373–2377
- Twentyman P R. Comparative chemosensitivity of exponential-versus plateau-phase cells in both in vitro and in vivo model systems. Cancer Treat Rep 1976; 60: 1719–1722
- Collins J L, Patek P Q, Cohn M. Tumorigenicity and lysis by natural killers. J Exptl Med 1981; 153: 89–106
- Patek P Q, Collins J L, Cohn M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature 1978; 276: 510–511
- Soule H D, Vazquez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409–1416
- Sykes J A, Whitescarver J, Jernstrom P, et al. Some properties of a new epithelial cell line of human origin. J Natl Cancer Inst 1970; 45: 107–122
- Collins J L, Patek P Q, Lin Y, et al. The cloned cell line L10.A2.J expresses natural cytotoxic activity. Cell Immunol 1986; 103: 191–198
- The analysis of variance. Discrete Multivariant Analysis, Y MM Bishop, S E Fienberg, P W Holland. Boston, MIT Press 1975; 396–398
- Alberts D S, Chen H SB. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Cloning of Human Tumor Cells, S E Salmon. Alan R. Liss Inc., New York 1980; 351–359
- Bateman J C, Carlton H N, Calvert R C. Investigation of distribution and excretion of 14C tagged triethylene thiophosphamide following injection by various routes. Int J Appl Radiat Isot 1960; 7: 287–298
- Vanderslice E W, Liu D, Collins J L. Culture conditions regulate the expression of transformation by cloned transformed cells. Int J Cancer 1989, (in press)